ArticleAnnals of hematology2026
Whole-exome sequencing identifies a CD38 variant in a Chinese family with hodgkin's lymphoma.
Article in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hodgkin's lymphoma (HL) exhibits genetic susceptibility, but little is known about the pathogenic genes associated with the disease. Herein, we present a case of two siblings from a consanguineous Chinese family who were both diagnosed with nodular sclerosis classical HL. The female child and male child were diagnosed at the ages of 22 and 29, respectively, both presenting with involvement of the neck and mediastinal lymph nodes, and poor response or relapse shortly after the first-line treatment. Whole-exome sequencing of the four family members revealed a novel pathogenic missense mutation in the CD38 gene (c.418 C > T, p.Arg140Trp), which was found to be inherited in an autosomal recessive manner. Herein, we identified a putative pathogenic genetic variant that may be associated with HL, which will contribute to improve the understanding of the genetic molecular mechanisms underlying the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.